UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Psychosocial/Behavioral Intervention in Post-Stroke Depression
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Behavioral: Modified cognitive behavioral therapy plus problem-solvingOther: usual care
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-09-23
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 101
- Registration Number
- NCT00194454
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 64
- Registration Number
- NCT00194402
- Locations
- 🇺🇸
Northwest Lipid Research Clinic, University of Washington, Seattle, Washington, United States
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
Phase 3
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 181
- Registration Number
- NCT00194571
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
Phase 1
Completed
- Conditions
- Stage IV Breast CancerHER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Ovarian Cancer
- Interventions
- Biological: HER-2/neu Peptide VaccineOther: Laboratory Biomarker Analysis
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 22
- Registration Number
- NCT00194714
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Treatment of Suicidal Women With Borderline Personality Disorder
Phase 2
Completed
- Conditions
- Borderline Personality DisorderSuicide
- Interventions
- Behavioral: Standard dialectical behavior therapy (SDBT)Behavioral: Individual DBT with no DBT group sessions (DBT-I)Behavioral: Group Skills DBT with no DBT individual sessions (DBT-S)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 99
- Registration Number
- NCT00183651
- Locations
- 🇺🇸
University of Washington, Department of Psychology, Behavior Research and Therapy Clinics, Seattle, Washington, United States
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease
Not Applicable
Completed
- Conditions
- Alzheimer DiseaseSleep Initiation and Maintenance Disorders
- Interventions
- Behavioral: Routine Medical Care with EducationBehavioral: Walking ProgramBehavioral: Light Exposure ProgramBehavioral: Combined Education, Walking and Light Exposure Program
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-01-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 132
- Registration Number
- NCT00183378
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Reducing Vaginal Infections in Women
Phase 3
Completed
- Conditions
- Bacterial DiseasesOther MycosesSexually Transmitted Infection
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 400
- Registration Number
- NCT00170430
- Locations
- 🇰🇪
Ganjoni Municipal Communicable Diseases Control Centre, Mombasa, Kenya
Prazosin Alcohol Dependence IVR Study
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2008-02-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 23
- Registration Number
- NCT00167687
- Locations
- 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States
ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
Phase 2
Completed
- Conditions
- HIV Infections
- Interventions
- Drug: Combined short-course zidovudine/nevirapineDrug: HAART
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 58
- Registration Number
- NCT00167674
- Locations
- 🇰🇪
University of Nairobi, Nairobi, Kenya
Nursing Management of Irritable Bowel Syndrome:Improving Outcomes
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Behavioral: cognitive-behavioral
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2009-05-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 188
- Registration Number
- NCT00167635
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸Northgate Executive 1, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath